NVO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today, Novo Nordisk A/S's share price is $48.73. Novo Nordisk A/S's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2014 was $1.40. Hence, Novo Nordisk A/S's Price-to-Free-Cash-Flow Ratio for today is 36.30.
During the past 13 years, Novo Nordisk A/S's highest Price-to-Free-Cash-Flow Ratio was 47.01. The lowest was 12.10. And the median was 23.13.
During the past 12 months, the average Free Cash Flow per Share Growth Rate of Novo Nordisk A/S was 5.60% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 15.40% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 17.80% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 25.50% per year.
During the past 13 years, Novo Nordisk A/S's highest 3-Year average Free Cash Flow per Share Growth Rate was 128.90% per year. The lowest was -23.90% per year. And the median was 19.95% per year.
Novo Nordisk A/S's Price-to-Free-Cash-Flow ratio for today is calculated as
|Price-to-Free-Cash-Flow Ratio||=||Share Price||/||Free Cash Flow per Share (TTM)|
Novo Nordisk A/S's Share Price of today is $48.73.
Novo Nordisk A/S's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2014 was 0.36 (Sep. 2013 ) + 0.31 (Dec. 2013 ) + 0.23 (Mar. 2014 ) + 0.5 (Jun. 2014 ) = $1.40.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, managements decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Novo Nordisk A/S Annual Data
Novo Nordisk A/S Quarterly Data